Colgate-Palmolive officer proposes $1.97M share sale

Tsourapas also reported selling 10,000 common shares on August 24, 2026, during the prior three months.

Available on EDGAR 11/04/2026 - 04:09 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Colgate-Palmolive officer Panagiotis Tsourapas reported a proposed sale of 19,938 common shares, with an approximate sale date of November 4, 2026. The shares are described in connection with an employee stock-option exercise through a broker-assisted cashless exercise. The proposed shares are listed at an aggregate market value of $1,968,709.79.

Key Figures

Proposed sale: 19,938 shares Aggregate market value: $1,968,709.79 Common shares outstanding: 794,920,513 shares +2 more

5 metrics

Proposed sale 19,938 shares Approximate sale date: November 4, 2026

Aggregate market value $1,968,709.79 Shares proposed for sale

Common shares outstanding 794,920,513 shares Reported in the securities information

Shares sold in prior three months 10,000 shares Sale date: August 24, 2026

Aggregate value of prior sale $920,477.17 10,000 common shares sold on August 24, 2026

Key Terms

employee stock options, broker assisted cashless exercise, Rule 144

3 terms

employee stock options financial

"Exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

broker assisted cashless exercise financial

"Broker assisted cashless exercise"

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CL shares did Panagiotis Tsourapas propose to sell?

Panagiotis Tsourapas, an officer of Colgate-Palmolive, reported a proposed sale of 19,938 common shares, with an approximate sale date of November 4, 2026. The shares are described in connection with an employee stock-option exercise through a broker-assisted cashless exercise.

How many CL shares did Panagiotis Tsourapas sell in the prior three months?

Panagiotis Tsourapas reported selling 10,000 common shares on August 24, 2026, during the prior three months. The reported value of those shares was $920,477.17.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001576945
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COLGATE PALMOLIVE CO
SEC File Number	001-00644
Address of Issuer	300 PARK AVE NEW YORK NEW YORK 10022
Phone	2123102000
Name of Person for Whose Account the Securities are To Be Sold	Tsourapas Panagiotis
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	19938	1968709.79	794920513	11/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/04/2026	Exercise of employee stock options	COLGATE PALMOLIVE CO			19938	11/04/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Panagiotis Tsourapas 300 PARK AVE NEW YORK NY 10022	Common Stock	08/24/2026	10000	920477.17

144: Remarks and Signature

Remarks
Date of Notice	11/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Panagiotis Tsourapas
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)